Abstract
In this study we evaluate prognostic factors that predict local-regional control and survival following stereotactic radiosurgery (SRS) in patients with brain metastasis and establish guidelines for patient selection. Our evaluation is based on 73 patients with brain metastasis treated with SRS at the University of Minnesota between March 1991 and November 1995. The ability of stereotactic radiosurgery to improve local control in patients with brain metastases is confirmed in our study in which only 6 of 62 patients failed locally after SRS, with an actuarial local progression-free survival of 80% at 2 years. Variables that predicted worse prognosis were larger tumor size (p=0.05) for local progression-free survival and multiplicity of metastasis (p=0.03) and infratentiorial location of metastases (p=0.006) for regional progression-free survival. Absence of extracranial disease, KPS ≥ 70, and single intracranial metastasis were significant predictors of longer survival. Patients who fulfill all three criteria will survive longer after SRS (MS=17.7 months) and will most likely benefit from the increase local control in the brain achieved by SRS. Survival in patients who do not meet any of these criteria is very poor (MS=1.5 months), and these patients are less likely to benefit from this treatment. Careful selection of patients for SRS is warranted.
Similar content being viewed by others
References
Cairncross JG, Kim JH, Posner JB: Radiation therapy for brain metastases. Ann Neurol 7: 529-541, 1980
Percy AK, Elveback LR, Okazaki H: Neoplasms of central nervous system: epidemiologic considerations. Neurology 22: 40-48, 1972
Silverberg E, Lubera JA: Cancer statistics, 1988. CA 38: 5-22, 1988
Walker AE, Robins M, Weinf Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 35: 219-226, 1985
Borgelt B, Gelber R, Kramer S, Brady LW, Chang CH, Davis LW, Perez CA, Hendrickson FR: The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6: 1-9, 1980
Nussbaum ES, Djalilian HR, Cho KH, Hall HA: Brain metastases: histology, multiplieity, surgery and survival. Cancer 78: 1781-1788, 1996
Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322: 494-499, 1990
Vecht CJ, Haaxma-Reiche H, Noordijk EM, Padberg GW, Voormolen JHC, Hoekstra FH, Tans JThJ, Hermans J: Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 33: 583-901, 1993
Alexander E III, Moriarty TM, Davis RB, Wen PY, Fine HA, Black PM, Kooy HM, Loeffler JS: Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastasis. J Natl Cancer Inst 87: 34-40, 1995
Auchter RM, Lamond JP, Alexander E, III, Buatti JM, Chappell R, Friedman WA, Kinsella TJ, Levin AB, Noyes WR, Schultz CJ, Loeffler JS, Mehta MP: A multi-institutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 35: 27-35, 1996
Flickinger JC, Kondziolka D, Lunsford LD, Coffey RJ, Goodman ML, Shaw EG, Hudgins WR, Weiner R, Harsh GR, IV, Sneed PK, Larson DA: A multi-institutional experience with stercotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28: 797-802, 1994
Joseph J, Adler JR, Cox RS, Hancock SL: Linear accelerator-based stereotaxic radiosurgery for brain metastases: the influence of number of lesions on survival. J Clin Oncol 14: 1085-1092, 1996
Kihlstrom L, Karlsson B, Lindquist C: Gamma knife surgery for cerebral metastases — implications for survival based on 16 years experience. Stereotact Funct Neurosurg 61(suppl 1): 45-50, 1993
Loeffler JS, Alexander E III: Radiosurgery for the treatment of intracranial metastases. In: Alexander E III, Loeffler JS, Lunsford LD (eds) Stereotactic Radiosurgery. McGraw Hill, New York 197-206, 1993
Loeffler JS, Kooy HM, Wen PY, Fine HA, Cheng C, Mannarino EG, Tsai JS, Alexander E III: The treatment of recurrent brain metastases with stereotactic radiosurgery. J Clin Oncol 8: 576-582, 1990
Buatti JM, Friedman WA, Bova FJ, Mendenhall WM: Treatment selection factors for stereotactic radiosurgery of intracranial metastases. Int J Radiat Oncol Biol Phys 32: 1161-1166, 1995
Smalley SR, Schray MF, Laws ER Jr, O'Fallon JR: Adjuvant radiation therapy after surgical resection of solitary brain metastasis: association with pattern of failure and survival. Int J Radiat Oncol Biol Phys 13: 1611-1616, 1987
Fuller BG, Kaplan ID, Adler J, Cox RS, Bagshaw MA: Stercotaxic radiosurgery for metastases: the importance of adjuvant whole brain irradiation. Int J Radiat Oncol Biol Phys 23: 413-418, 1992
Cairncross JG, Posner JB: The management of brain metastases. In: Walker MD (ed) Oncology of the Nervous System. Vol 12 of Cancer Treatment and Research. Martinus Nijhoff, Boston 1983, pp. 341-377
Mehta MP, Rozental JM, Levin AB, Mackie TR, Kubsad SS, Gehring MA, Kinsella TJ: Defining the role of radiosurgery in the management of brain metastases. Int J Radiat Oncol Biol Phys 24: 619-625, 1992
Zimm S, Wampler GL, Stablein D, Hazra T, Young HF: Intracerebral metastasos in solid tumor patients. Natural history and results of treatment. Cancer 48: 384-394, 1981
Somaza S, Kondziolka D, Lunsford LD, Kirkwood JM, Frickinger JC: Stereotactic radiosurgery for cerebral metastatic melanoma. Neurosurg 79: 661-666, 1993
Flickinger JC, Lunsford LD, Konziolka D, Kirkwood JM: Radiosurgery of brain metastases with or without whole brain radiotherapy. Proceedings of the 74th Annual Meetings of the American Radium Society. Orlando, FL, April 11–15, 1992
Fadul C, Misulis KE, Wiley RG: Cerebellar metastases: diagnostic and management considerations. J Clin Oncol 5: 1107-1115, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cho, K.H., Hall, W.A., Gerbi, B.J. et al. Patient selection criteria for the treatment of brain metastases with stereotactic radiosurgery. J Neurooncol 40, 73–86 (1998). https://doi.org/10.1023/A:1006169109920
Issue Date:
DOI: https://doi.org/10.1023/A:1006169109920